Chemical Structure : EBL-3647
Catalog No.: PC-22092Not For Human Use, Lab Use Only.
EBL-3647 is a novel LpxH inhibitor with IC50 of 2.2 nM for E. coli LpxH enzyme, shows potent activity targeting lipopolysaccharide synthesis in Gram-negative bacteria (K. pneumoniae ATCC 13883, MIC 0.5 mg/mL).
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
EBL-3647 is a novel LpxH inhibitor with IC50 of 2.2 nM for E. coli LpxH enzyme, shows potent activity targeting lipopolysaccharide synthesis in Gram-negative bacteria (K. pneumoniae ATCC 13883, MIC 0.5 mg/mL).
EBL-3647 has potent in vivo efficacy against bloodstream infections caused by the critical Gram-negative pathogens E. coli and Klebsiella pneumoniae.
EBL-3647 has potent in vitro activity against a diverse range of clinical E. coli and K. pneumoniae isolates, irrespective of the resistance genotype.
M.Wt | 667.80 | |
Formula | C30H37N9O5S2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Huseby DL, et al. Proc Natl Acad Sci U S A. 2024 Apr 9;121(15):e2317274121.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright